Nova R Wealth, Inc. Amgen Inc Transaction History

Nova R Wealth, Inc.

$194 Million
Q3 2024

A detailed history of Nova R Wealth, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Nova R Wealth, Inc. holds 12,348 shares of AMGN stock, worth $3.64 Million. This represents 2.05% of its overall portfolio holdings.

Number of Shares

12,348

Previous 12,245 0.84%

Holding current value

$3.64 Million

Previous $3.83 Million 4.0%

% of portfolio

2.05%

Previous 2.06%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$309.38 - $337.38 $31,866 - $34,750	103 Added 0.84%	12,348 $3.98 Million
Q2 2024 Jul 18, 2024	BUY	$262.75 - $319.31 $1,051 - $1,277	4 Added 0.03%	12,245 $3.83 Million
Q1 2024 Apr 12, 2024	BUY	$268.87 - $324.56 $537 - $649	2 Added 0.02%	12,241 $3.48 Million
Q4 2023 Jan 19, 2024	BUY	$255.7 - $288.46 $511 - $576	2 Added 0.02%	12,239 $3.53 Million
Q3 2023 Oct 18, 2023	BUY	$218.65 - $271.46 $437 - $542	2 Added 0.02%	12,237 $3.29 Million
Q2 2023 Jul 27, 2023	SELL	$214.27 - $253.37 $73,066 - $86,399	-341 Reduced 2.71%	12,235 $2.72 Million
Q1 2023 Apr 17, 2023	BUY	$225.79 - $275.2 $1,128 - $1,376	5 Added 0.04%	12,576 $3.04 Million
Q4 2022 Jan 31, 2023	SELL	$229.03 - $291.01 $5,725 - $7,275	-25 Reduced 0.2%	12,571 $3.3 Million
Q3 2022 Oct 25, 2022	SELL	$224.46 - $253.15 $6,958 - $7,847	-31 Reduced 0.25%	12,596 $2.84 Million
Q2 2022 Jul 15, 2022	BUY	$230.71 - $256.74 $9,689 - $10,783	42 Added 0.33%	12,627 $3.07 Million
Q1 2022 May 10, 2022	SELL	$219.27 - $242.57 $8,332 - $9,217	-38 Reduced 0.3%	12,585 $3.04 Million
Q4 2021 Jan 27, 2022	BUY	$198.88 - $227.6 $2.51 Million - $2.87 Million	12,623 New	12,623 $2.84 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nova R Wealth, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nova R Wealth, Inc. with notifications on news.

Account